Renal replacement therapy in acute kidney injury from a Chinese cross-sectional study: patient, clinical, socioeconomic and health service predictors of treatment
- PMID: 28472927
- PMCID: PMC5418849
- DOI: 10.1186/s12882-017-0567-9
Renal replacement therapy in acute kidney injury from a Chinese cross-sectional study: patient, clinical, socioeconomic and health service predictors of treatment
Abstract
Background: Renal replacement therapy (RRT) is important to support critically ill patients with acute kidney injury (AKI). This study, a part of a nation-wide survey for AKI conducted by the ISN AKF 0 by 25 China Consortium, aims to study the current RRT practical situation and problems in China.
Methods: The current study is a part of a nation-wide survey for AKI conducted by ISN AKF 0 by 25 China Consortium. The survey included 44 sites all over the country, including 22 academic hospitals in big cities and 22 local hospitals in smaller cities or rural areas. Of the 44 sites, all have access to PD and IHD, 93.5% are capable to perform CRRT. Of total 7604 AKI cases, 896 cases (11.8%) had indications for RRT and were included in the current abstract.
Results: of the 896 patients that had indications for RRT, only 59.3% received RRT. Patients who were older, male, from lower income areas, in local hospitals, or with severe comorbidities, were less likely to receive RRT. RRT treatment was associated with lower mortality (OR = 0.58, 95%CI 0.38-0.89). The RRT modalities were continuous renal replacement therapy (CRRT) in 53.9%, intermittent hemodialysis (IHD) in 38.0%, CRRT complemented by IHD in 6.2%, CRRT complemented by peritoneal dialysis (PD) in 0.8% and PD in 1.1%. Of the subgroup of patients receiving RRT who did not have an indication for modality of CRRT, 36.8% in fact received CRRT, and their medical cost and mortality rate was higher (7944[4248, 16,055] vs. 5100[2948, 9396] US dollars, p < 0.001 and 10.6% vs. 4.4%, p = 0.047, respectively) compared with those treated with other RRT modalities).
Conclusions: Extrapolated to the whole of China our results indicate that an estimated 139,000 patients with an indication of RRT are under treated without RRT over a year. Non-clinical factors influence RRT prescription for severe AKI patients. CRRT may be over-utilized in the treatment of severe AKI and the use of PD is extremely rare. These findings have implications for the effective application of medical resources in the treatment of severe AKI.
Keywords: Acute kidney injury; China; Developing countries; Hemodialysis; Peritoneal dialysis; Renal replacement therapy.
Figures
Similar articles
-
Initial renal replacement therapy (RRT) modality associates with 90-day postdischarge RRT dependence in critically ill AKI survivors.J Crit Care. 2024 Aug;82:154764. doi: 10.1016/j.jcrc.2024.154764. Epub 2024 Mar 8. J Crit Care. 2024. PMID: 38460295
-
Renal replacement therapy practices for patients with acute kidney injury in China.PLoS One. 2017 Jul 10;12(7):e0178509. doi: 10.1371/journal.pone.0178509. eCollection 2017. PLoS One. 2017. PMID: 28692694 Free PMC article.
-
[Prediction of acute kidney injury in critically ill patients treated with intermittent hemodialysis versus CRRT].Rev Med Inst Mex Seguro Soc. 2017 Nov-Dec;55(6):696-703. Rev Med Inst Mex Seguro Soc. 2017. PMID: 29190861 Spanish.
-
Renal replacement therapy in the ICU: intermittent hemodialysis, sustained low-efficiency dialysis or continuous renal replacement therapy?Curr Opin Crit Care. 2018 Dec;24(6):437-442. doi: 10.1097/MCC.0000000000000541. Curr Opin Crit Care. 2018. PMID: 30247213 Review.
-
Early versus late initiation of renal replacement therapy in patients with acute kidney injury-a systematic review & meta-analysis of randomized controlled trials.BMC Nephrol. 2017 Feb 28;18(1):78. doi: 10.1186/s12882-017-0486-9. BMC Nephrol. 2017. PMID: 28245793 Free PMC article.
Cited by
-
Late restoration of renal function in patients with severe ANCA-associated glomerulonephritis who were dialysis-dependent at presentation.Clin Rheumatol. 2018 Aug;37(8):2143-2150. doi: 10.1007/s10067-018-4100-8. Epub 2018 Apr 20. Clin Rheumatol. 2018. PMID: 29679168
-
Cost-effectiveness analysis of polymyxin B versus colistin for treating patients with carbapenem-resistant gram-negative bacterial infections.Sci Rep. 2024 Oct 9;14(1):23635. doi: 10.1038/s41598-024-74290-y. Sci Rep. 2024. PMID: 39384871 Free PMC article.
-
Urgent Implantation of Peritoneal Dialysis Catheter in Chronic Kidney Disease and Acute Kidney Injury-A Review.J Clin Med. 2023 Aug 2;12(15):5079. doi: 10.3390/jcm12155079. J Clin Med. 2023. PMID: 37568481 Free PMC article. Review.
-
A multi-center cross-sectional study on blood purification among adult patients in intensive care unit in China: a study protocol.Chin Med J (Engl). 2019 May 20;132(10):1208-1211. doi: 10.1097/CM9.0000000000000180. Chin Med J (Engl). 2019. PMID: 30882465 Free PMC article.
-
Cost-effectiveness analysis of ceftazidime-avibactam as definitive treatment for treatment of carbapenem-resistant Klebsiella pneumoniae bloodstream infection.Front Public Health. 2023 Feb 28;11:1118307. doi: 10.3389/fpubh.2023.1118307. eCollection 2023. Front Public Health. 2023. PMID: 36926178 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources